Xigduo Xr 10Mg/500Mg 6X5 30'S

Xigduo XR is an extended-release prescription medication containing a combination of dapagliflozin (10mg) and metformin HCl (500mg). Manufactured by AstraZeneca, each pack contains 30 tablets designed for the management of type 2 diabetes with a controlled release mechanism for optimal effectiveness. This medication is manufactured, packed and released by AstraZeneca Pharmaceuticals LP in Mount Vernon, Indiana, USA. The marketing authorization is held by AstraZeneca AB SE-151 85 Södertälje Sweden. Xigduo is a registered trademark of the AstraZeneca group of companies. The extended-release formulation helps provide steady medication levels throughout the day.